Skip to content
Recall Observatory FDA recall evidence

Drug product

Nortriptyline HCl Capsules, USP equivalent to 10mg base Mfd. by: Taro Pharmaceutical Industries Ltd. Haifa Bay, Israel 2624761 Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532 NDC 51672-4001-1

D-0246-2021

January 08, 2021

Class II

Product summary

Firm
Taro Pharmaceuticals U.S.A., Inc.
Event
Event 87152
Status
Terminated
Classification
Class II
Quantity
44,256 bottles
Official record key
drug-enforcement:D-0246-2021

Official wording

Reason: CGMP deviations.

Code information: AC05096, AC05098, and AC05099; Exp 10/31/2022

Distribution pattern: Nationwide

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP deviations